Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-23T01:15:00.408Z Has data issue: false hasContentIssue false
  • English
  • Français

Physical health problems in schizophrenia and other serious mental illnesses

Published online by Cambridge University Press:  01 July 2007

Cherian Sebastian  and
M Dominic Beer
Cherian Sebastian*
Affiliation:
Staff Grade Psychiatrist Oxleas NHS Foundation Trust
M Dominic Beer
Affiliation:
Consultant Psychiatrist Oxleas NHS Foundation Trust and Honorary Senior Lecturer (Institute of Psychiatry, University of London)
*
Correspondence to: Dr M.D. Beer, The Bracton Centre, Oxleas NHS Foundation Trust, Bracton Lane, Dartford, Kent DA2 7AF, UK; Email: [email protected]
Get access

Abstract:

Background: Physical illnesses are more prevalent among patients with serious and enduring mental illnesses. This is mainly due to the association between mental and physical illnesses, complications of the mental illness itself and as a side effect of medication. Medical problems can be overlooked by psychiatrists due to several reasons. More research and audit of the existing services are necessary to establish the physical needs of patients with complex mental health problems.

Aim: To give an account of the causes of excessive mortality and physical morbidity among patients with serious mental health problems.

Method: Review of the worldwide literature.

Results: Physical problems are more common and the standardised mortality rate (SMR) is higher in psychiatric patients compared to the general population. The main causes are association between mental and physical illnesses, lifestyle including lack of physical activity, smoking and poor dietary habits, metabolic syndrome, diabetes mellitus and other cardiac risk factors. There is a close association between treatment with antipsychotic medication and weight gain, diabetes mellitus, sudden death, cardiac and endocrine complications such as QT prolongation and also hyperprolactinemia.

Conclusion: The paper highlights the importance of monitoring physical problems in patients with serious and enduring mental illnesses. Good practice points include help with smoking cessation, psycho-education about healthy lifestyle, close liaison between carers and professionals, the importance of taking baseline investigations before commencing antipsychotics, a shared care approach with primary care, early identification of the risk factors for physical illnesses and regular monitoring of physical health. Also important are social interventions such as appropriate accommodation and structured day, leisure and sporting activities.

Keywords

Physical healthschizophreniametabolic syndromerisk factorsdiabetes mellitusantipsychotic medicationcardiac arrhythmiasendocrine illnesses
Type
Original Article
Information
Journal of Psychiatric Intensive Care , Volume 3 , Issue 2 , July 2007 , pp. 101 - 111
Copyright
Copyright © NAPICU 2007

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Allison, D.B., Mentore, J.L., Heo, M., Chandler, L.P., Cappelleri, J.C., Infante, M.C. and Weiden, P.J. (1999) Antipsychotic-induced weight gain: A comprehensive research synthesis. American Journal of Psychiatry. 156(11): 1686–1696.CrossRefGoogle ScholarPubMed
Bergemann, N. (2001) Hypo-oestrogenism in Schizophrenic women. Archives of Women's Mental Health. 3(suppl.2):s154.Google Scholar
British National Formulary (2007) London: BMJ Publishing and Royal Pharmaceutical Society of Great Britain. 54(September): section 4.3.Google Scholar
Brown, S., Inskip, H. and Barraclough, B. (2000) Causes of the excess mortality of schizophrenia. British Journal of Psychiatry. 177: 212–217.CrossRefGoogle ScholarPubMed
Canuso, C.M., Goldstein, J.M., Wojcick, J., Dawson, R., Brandman, D., Klibanski, A., Schildkraut, J.J. and Green, A.I. (2002) Antipsychotic medication, prolactin elevation, and ovarian function in women with schizophrenia and schizoaffective disorder. Psychiatry Research. 111: 11–20.CrossRefGoogle ScholarPubMed
Connolly, M., and Kelly, C. (2005) Life style and physical health in schizophrenia. Advances in Psychiatric Treatment. 11: 125–132.CrossRefGoogle Scholar
Cormac, I., Martin, D.and Ferriter, M. (2004) Improving the physical health of long-stay psychiatric inpatients. Advances in Psychiatric Treatment. 10: 107–115.CrossRefGoogle Scholar
Dixon, L., Weiden, P., Delahanti, J., Goldberg, R., Postrado, L., Lucksted, A. and Lehman, A. (2000) Prevalence and correlates of diabetes in national schizophrenia samples. Schizophrenia Bulletin. 26: 903–912.CrossRefGoogle ScholarPubMed
Garden, G. (2005) Physical examination in psychiatric practice, Advances in Psychiatric Treatment. 11: 142–149.CrossRefGoogle Scholar
Gupta, S., Steinmeyer, C., Frank, B., Madhusoodanan, S., Lockwood, K., Lentz, B. and Keller, P. (2003) Hyperglycaemia and hyper tri-glyceridemia in real world patients on antipsychotic therapy. American Journal of Therapeutics. 10: 348–355.CrossRefGoogle Scholar
Holt, R.I.G. (2004) Diagnosis, epidemiology and pathogenesis of diabetes mellitus: an update for psychiatrists, British Journal of Psychiatry. 184(suppl.47): s55–s63.CrossRefGoogle Scholar
Hughes, S. (1991) The physical examination in psychiatry. Psychiatric Bulletin. 15: 615–616.CrossRefGoogle Scholar
Kelly, C. and McCreadie, R. (2000) Cigarette smoking and schizophrenia Advances in Psychiatric Treatment. 6: 327–332.CrossRefGoogle Scholar
Kendrick, T. (1996) Cardiovascular and respiratory risk factors and symptoms among general practice patients with long term mental illness. British Journal of Psychiatry. 169: 733–739.CrossRefGoogle ScholarPubMed
Koran, M., Harold, C.S. et al. (1989) Medical evaluation of psychiatric patients. I. Results in a state mental health system. Archives of General Psychiatry. 46: 733–740.CrossRefGoogle Scholar
Lambert, T.J.R., Velakoulis, D. and Pantelis, C. (2003) Medical co-morbidity in schizophrenia. Medical Journal of Australia. 178: 67–70.CrossRefGoogle ScholarPubMed
Lawrence, D.M., Holman, C.D.J., Jablensky, A.V. and Hobbs, M.S.T. (2003) Death rate from ischemic heart disease in Western Australian psychiatric patients 1980–1998. British Journal of Psychiatry. 182: 31–36.CrossRefGoogle ScholarPubMed
McCreadie, R.G. (2003) Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study. British Journal of Psychiatry. 183: 534–539.Google ScholarPubMed
Metherall, A., Worthington, R. and Keyte, A. (2006) Twenty four hour medical emergency response teams in a mental health in-patient facility – New approaches for safer restraint. Journal of Psychiatric Intensive Care. 2: 21–29.CrossRefGoogle Scholar
Modai, I., Hirschmann, S., Rava, A., Kurs, R., Barak, P., Lichtenberg, P. and Ritsner, M. (2000) Sudden death in patients receiving clozapine treatment: A Preliminary Investigation. Journal of Clinical Psychopharmacology. 20(3): 325–327.CrossRefGoogle ScholarPubMed
O'Brien, P. and Oyebode, F. (2003) Psychotropic medication and the heart Advances in Psychiatric Treatment. 9: 414–423.CrossRefGoogle Scholar
Rettenbacher, M.A. (2005) Disturbances of glucose and lipid metabolism during treatment with new generation antipsychotics. Current Opinion in Psychiatry. 18: 175–179.CrossRefGoogle ScholarPubMed
Royal College of Psychiatrists (1997) The association between antipsychotic drugs and sudden death (Council report CR57). London: Royal College of Psychiatrists.Google Scholar
Ryan, M.C.M., Collins, P.and Thakore, J.H. (2003) Impaired fasting glucose tolerance in first episode drug naïve patients with schizophrenia. American Journal of Psychiatry. 160: 284–289.CrossRefGoogle ScholarPubMed
Sebastian, C., and Beer, M.D. (2006) Physical health of psychiatric patients admitted to a low secure challenging behaviour unit. Journal of Psychiatric Intensive Care. 1: 77–83.CrossRefGoogle Scholar
Sernyak, M.J., Leslie, D.L., Alarcon, R.D., Losonczy, M.F. and Roesnheck, R.A. (2002) Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. American Journal of Psychiatry. 159(4): 561–566.CrossRefGoogle ScholarPubMed
Smith, S., Wheeler, M.J., Murray, R., and O'Keane, V. (2002) The effects of antipsychotic-induced hyper prolactinaemia on the hypothalamic-pituitary-gonadal axis. Journal of Clinical Psychopharmacology. 22(2): 109–114.CrossRefGoogle Scholar
Taylor, D.M. and McAskil, R. (2000) Atypical antipsychotics and weight gain: A systematic review. Acta Psychiatrica Scandinavica. 101(6): 416–432.CrossRefGoogle ScholarPubMed
Thakore, J.H. (2004) Metabolic disturbances in first episode schizophrenia. British Journal of Psychiatry. 184(suppl. 47): s76–s79.CrossRefGoogle Scholar
Thakore, J.H. (2005) Physical health of patients with schizophrenia. Psychiatry. 4(11): 58–60.CrossRefGoogle Scholar
Weick, A. and Haddad, P.M. (2003) Antipsychotic-induced hyper prolactinaemia in women: Patho-physiology, severity and consequences. Selective literature review. British Journal of Psychiatry. 182: 199–204.CrossRefGoogle Scholar
World Federation for Mental Health (2004) The impact of physical health problems for persons with severe mental disorders. In: The relationship between physical and mental health: Co-occurring disorders www.wfmh.org/wmhday/WMHD2004EnglishSection1.pdfGoogle Scholar
Zhang, Z.-J., Yao, Z.-j, Liu, W., Fang, Q.and Reynolds, G.P. (2004) Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia. British Journal of Psychiatry. 184: 58–62.CrossRefGoogle ScholarPubMed